Step 1 topics → Gastrointestinal → H2 Receptor Blockers

H2 Receptor Blockers

USMLE Step 1 trap: Generalizes cimetidine's CYP450 inhibition to all H2 blockers. Cimetidine is a potent CYP450 inhibitor causing significant drug interactions (e.g., warfarin, theophylline, phenytoin); other H2 blockers (ranitidine, famotidine) have minimal CYP450 effects.

H2 receptor blockers competitively block histamine H2 receptors on gastric parietal cells, reducing cAMP and decreasing acid secretion. USMLE Step 1 tests this class in two main ways: understanding why they're less effective than PPIs mechanistically, and knowing what makes cimetidine different from the rest of the class. If you treat all H2 blockers as interchangeable, you will miss questions — cimetidine has a pharmacological profile that's essentially its own topic.

The mechanism angle is subtle. Students often assume H2 blockers shut off acid production, but they only block one of three stimulatory inputs to parietal cells. Gastrin and acetylcholine can still drive acid secretion independently. PPIs work downstream at the H+/K+ ATPase pump — the final common pathway — which is why they're more complete inhibitors. This distinction shows up in clinical vignettes where H2 blockers underperform.

The cimetidine angle is a classic USMLE Step 1 favorite. Cimetidine is a potent CYP450 inhibitor and an androgen receptor blocker — two effects the other H2 blockers (ranitidine, famotidine, nizatidine) simply don't share. If a vignette describes a man on an H2 blocker who develops gynecomastia or impotence, or a patient whose warfarin levels spike, the drug is cimetidine. Generalizing those effects to the entire class is a trap the exam sets deliberately.

From real student decks
73%have cards covering this topic
51%have mature cards

Common misconceptions

Common mistake
Wrong: All H2 blockers equally inhibit cytochrome P450 enzymes and cause drug interactions.
Right: Cimetidine is a potent CYP450 inhibitor causing significant drug interactions (e.g., warfarin, theophylline, phenytoin); other H2 blockers (ranitidine, famotidine) have minimal CYP450 effects.
Only cimetidine significantly inhibits cytochrome P450 enzymes — ranitidine has minimal effect and famotidine has essentially none. When a vignette describes an H2 blocker causing supratherapeutic drug levels or bleeding on warfarin, the answer is cimetidine specifically. Attributing this to the class as a whole will lead you to wrong answers when other H2 blockers are named.
Common mistake
Gap: Missing cimetidine's antiandrogenic endocrine side effects (gynecomastia, impotence)
Cimetidine has antiandrogenic effects causing gynecomastia, impotence, and decreased libido in men, and galactorrhea in women, due to androgen receptor blockade and increased prolactin.
Cimetidine blocks androgen receptors directly and also elevates prolactin levels — effects that are unique to this drug within the H2 blocker class. This means a man on long-term cimetidine can develop gynecomastia, impotence, or decreased libido, and a woman may develop galactorrhea. These endocrine side effects are a high-yield distinguishing feature that the exam uses to test whether you know cimetidine versus the rest of the class.
Common mistake
Wrong: H2 blockers completely abolish gastric acid secretion by blocking histamine.
Right: H2 blockers reduce but do not eliminate acid secretion because gastrin and acetylcholine can still stimulate parietal cells independently of histamine; PPIs block the final common pathway more completely.
Histamine is just one of three signals that activate parietal cells — gastrin and acetylcholine work through separate receptors and are unaffected by H2 blockade. This means parietal cells can still secrete acid via those remaining pathways, so H2 blockers provide incomplete suppression. PPIs block H+/K+ ATPase regardless of which upstream signal triggered the cell, which is why they produce more complete acid suppression and are preferred for severe disease like erosive esophagitis.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand why H2 blockers reduce but do not eliminate gastric acid secretion, and why PPIs are more potent — specifically because PPIs block the H+/K+ ATPase, the final common pathway, while H2 blockers still leave gastrin and acetylcholine stimulation intact.
  2. Recognize cimetidine's unique side effect profile: it is a strong CYP450 inhibitor that raises plasma levels of drugs like warfarin, theophylline, and phenytoin, and it blocks androgen receptors, causing gynecomastia, impotence, and decreased libido in men, and galactorrhea in women.

Can you avoid these mistakes?

A 58-year-old man on warfarin for atrial fibrillation is started on an H2 blocker for GERD. Two weeks later his INR is dangerously elevated. Which H2 blocker is most likely responsible, and what is the mechanism?
Why can a patient still secrete significant gastric acid despite being on a full dose of an H2 blocker? Which drug class addresses this limitation, and how?
A 45-year-old man has been taking cimetidine for peptic ulcer disease for 6 months. He reports decreased libido and his physician notices gynecomastia on exam. What is the mechanism of these findings, and would switching to famotidine resolve or prevent them?
A patient needs acid suppression but is also on theophylline for COPD. Which H2 blocker would be safest to prescribe, and why?

Related topics

Gastric Secretion and Cell Types Gut Tube Regions and Blood Supply Midgut Rotation and Anomalies (Malrotation/Volvulus) Meckel Diverticulum Omphalocele vs Gastroschisis

See how your Anki deck covers this topic.

Upload your deck for a free audit →